Evidence map›Paper›PMID 33533592›Full record

ArticleACS chemical biology2021

A Highly Efficacious Carfentanil Vaccine That Blunts Opioid-Induced Antinociception and Respiratory Depression.

Lisa M Eubanks, Steven Blake, Yoshihiro Natori, Beverly Ellis, Paul T Bremer, Kim D Janda

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Carfentanil Depresses Inspiratory Motor Drive.Journal of substance abuse and alcoholism · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Sudden Death Induced by Acute Inhalation of Aerosolized Carfentanil.Archives of clinical and biomedical research · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Catalytic Antibody Blunts Carfentanil-Induced Respiratory Depression.ACS pharmacology & translational science · 2023
    Article
  10. Article
  11. Article
  12. Trailblazing through the Opioid Epidemic. Will Science Prevail?Translational perioperative and pain medicine · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lisa M EubanksDepartments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0001-5288-6294
Steven BlakeDepartments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0002-3357-0515
Yoshihiro NatoriDepartments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0003-1126-1962
Beverly EllisDepartments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.
Paul T BremerDepartments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0002-8357-1743
Kim D JandaDepartments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0001-6759-4227
Scripps Research Institute · US

Funding

Gene Variants for Nicotine Withdrawal Deficits in LearningU01DA041632 · NIDA · PENNSYLVANIA STATE UNIVERSITY, THE · PI GOULD, THOMAS J · 2016 to 2020
$1.8M
Immunotherapy to Counteract Lethal Doses of CarfentanilU01DA046323 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI JANDA, KIM · 2019 to 2021
$1.6M
NIDA NIH HHS U01 DA041632NIDA NIH HHS U01 DA046323
6 · The paper itself

Abstract

The opioid epidemic remains a dire public health crisis with millions of people currently suffering from opioid use disorder (OUD) and tens of thousands dying each year. Synthetic opioids are most responsible for the crisis because of their extreme potency and ease of manufacture. Carfentanil for example has an estimated potency 10,000 times greater than morphine and thus is highly dangerous for human use. Herein, we report two synthetic opioid vaccines that elicited high-affinity antibodies against carfentanil and fentanyl with cross-reactivity to other synthetic opioids in mice and offered protection against opioid-induced respiratory depression, the primary cause of overdose deaths. These vaccines also successfully diminished drug biodistribution to the brain and shielded against opioid analgesic effects. Collectively, these findings provide new insights into the development of immunotherapeutic strategies aimed at opioid abuse and overdose.

Indexed as

AnimalsFentanylImmunoconjugatesMiceOpioid-Related DisordersRespiratory InsufficiencyTetanus ToxoidVaccines, SyntheticcarfentanilFentanylImmunoconjugatesTetanus ToxoidVaccines, Synthetic

Identifiers

PMID33533592
PMCPMC8260150
OpenAlexW3126733348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.